Burkina Faso slashes medicine prices in landmark health reform

The Government of Burkina Faso has announced a historic reduction in the cost of essential generic medicines and medical supplies, with price cuts reaching up to 72%. This bold move aims to enhance equitable access to healthcare across the nation.

Key details of the price reduction initiative

Following a 3 billion FCFA financial commitment, the new pricing policy will take effect on March 1, 2026. The reductions apply to medications distributed through the Central Purchasing Unit for Essential Generic Medicines (CAMEG), covering a wide range of treatments and supplies.

Breakdown of price reductions by category

• Tablets and capsules: Up to 67.27% reduction
• Injectable medications: Up to 53.47% reduction
• Syrups and suspensions: 20% reduction
• Medical consumables: Up to 72.73% reduction

Government’s commitment to affordable healthcare

Speaking on the initiative, Health Minister Dr. Robert Lucien Jean-Claude Kargougou highlighted the government’s dedication to lowering out-of-pocket healthcare expenses for citizens. The reform follows a previous price reduction in May 2025, which was estimated to save households nearly 5 billion FCFA annually.

The latest measure is part of a broader strategy to ensure high-quality, accessible medical care for all residents of Burkina Faso, reinforcing the country’s commitment to public health equity.

Impact on households and healthcare access

The price adjustments are expected to significantly ease the financial burden on families, particularly those relying on essential generic medicines. By making treatments more affordable, the government aims to improve overall health outcomes and reduce disparities in healthcare access across different regions of the country.

By Mariama Hamani — Analyst